Clinical trial
GLP_1 RA Ultrasound Study
Invitation only · Not applicable · 1 countries · Registry ID NCT06581120
What this study is about
The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.
Basic eligibility
Full registry criteria
Treatments and study arms
Glucagon-Like Peptide-1 receptor agonists
GLP-1 RAs: Glucagon like peptide-1 receptor agonists, this includes patients who are on Liraglutide, Semaglutide, Dulaglutide and Tirzepatide.Tirzepatide which is a combined GLP-1 RA/glucose-dependent insulinotropic polypeptide (GIP) agonist is included as a part of GLP-1 RAs.
Point of Care Gastric Ultrasound
A gastric ultrasound following a standard NPO period to determine gastric contents and risk of aspiration during surgery.
Primary outcomes
Difference between control group and GLP-1 group. Measured by Gastric contents during Point of Care Gastric Ultrasound.
Study locations
1 locations were listed when this page was built. The first 40 are shown.